Brain tumour
Short versus Long-term Levetiracetam in Brain Tumors
Who can joinAsk the trial team
AgeAsk the trial team
Kind of studyPhase 3: compared with usual treatment
What it testsA medicine
The full list of who can and cannot join is on the registry. Ask the trial team, or write to us and we will explain it in simple words.
Contact hospital
The registry names this hospital as the trial's main contact. Ask them which hospitals are taking patients.
Tata Memorial Centre MumbaiMumbaiDirections ↗
Registry summary (technical)
Short versus Long-term Levetiracetam in Brain Tumors: A Phase 3 Randomized Controlled Trial (LIBRA) - LIBRA
Sponsor: Tata Memorial Centre Mumbai
CTRI/2024/06/069498 on CTRI, India's trial registry
Source: Clinical Trials Registry – India (CTRI), via WHO ICTRP, data of 12 Oct 2026
Last updated on the registry 2 Feb 2026 · read by us 5 Nov 2026